Programmed death ligand 1 (pd-l1) expression in malignant mesenchymal tumors | Zendy

Kemal Kösemehmetoğlu | Zendy; Ece Özoğul | Zendy; Berrin Babaoğlu | Zendy; Gaye Güler Tezel | Zendy; Gökhan Gedikoğlu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Programmed death ligand 1 (pd-l1) expression in malignant mesenchymal tumors

Author(s) -

Kemal Kösemehmetoğlu,

Ece Özoğul,

Berrin Babaoğlu,

Gaye Güler Tezel,

Gökhan Gedikoğlu

Publication year - 2017

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2017.01395

Subject(s) - pathology , sarcoma , malignant peripheral nerve sheath tumor , synovial sarcoma , tissue microarray , liposarcoma , solitary fibrous tumor , immunohistochemistry , myxoid liposarcoma , dermatofibrosarcoma protuberans , undifferentiated pleomorphic sarcoma , hemangiopericytoma , myoepithelioma , medicine , biology , soft tissue sarcoma , myoepithelial cell , cd34 , stem cell , genetics

Programmed death ligand 1 (PD-L1) found on tumor cells has recently been reported to have a key role in the development and dissemination of many tumors, such as lung and breast carcinomas. In this study, we retrospectively analyzed PD-L1 expression among different types of sarcomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research